An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy

By Takahashi Toshiyuki   Konta Tsuneo   Takasaki Satoshi   Ichikawa Kazunobu   Takeishi Yasuchika   Kubota Isao  

Clinical and Experimental Nephrology, Vol. 11, Iss. 3, 2007-09 ,pp. : 202-208

Springer Publishing Company

Access to resources Recommend Favorite

Expression of bone type 1 PTH receptor in rats with chronic renal failure

By Kuwahara Michio   Inoshita Seiji   Nakano Yukiko   Terada Yoshio   Takano Yoshiro   Sasaki Sei  

Clinical and Experimental Nephrology, Vol. 11, Iss. 1, 2007-03 ,pp. : 34-40

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association of angiotensin II type 1 receptor A1166C gene polymorphism with the risk of end-stage renal disease

By Mao Song   Huang Songming  

Renal Failure, Vol. 35, Iss. 9, 2013-10 ,pp. : 1295-1301

Informa Healthcare

Access to resources Recommend Favorite

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade on Streptozotocin-Induced Diabetic Nephropathy

By Saniye Sen   Mehmet Kanter   Sedat Ustundag   Cevat Aktas   Dogutan Haluk   Omer Yalcin  

Renal Failure, Vol. 30, Iss. 10, 2008-11 ,pp. : 1023-1033

Informa Healthcare

Access to resources Recommend Favorite

The Role of Angiotensin II Receptor 1 (AT1) Blockade in Cisplatin-Induced Nephrotoxicity in Rats: Gender-Related Differences

By Haghighi Maryam   Nematbakhsh Mehdi   Talebi Ardeshir   Nasri Hamid   Ashrafi Farzaneh   Roshanaei Kambiz   Eshraghi-Jazi Fatemeh   Pezeshki Zahra   Safari Tahereh  

Renal Failure, Vol. 34, Iss. 8, 2012-09 ,pp. : 1046-1051

Informa Healthcare

Access to resources Recommend Favorite